(Q58291350)

English

Ritonavir-Boosted Tipranavir Demonstrates Superior Efficacy to Ritonavir-Boosted Protease Inhibitors in Treatment-Experienced HIV-Infected Patients: 24-Week Results of the RESIST-2 Trial

article

In more languages

edit

Statements

instance of

scholarly article

0 references

title

Ritonavir-Boosted Tipranavir Demonstrates Superior Efficacy to Ritonavir-Boosted Protease Inhibitors in Treatment-Experienced HIV-Infected Patients: 24-Week Results of the RESIST-2 Trial (English)

0 references

0 references

1 reference

F. Antunes

12

0 references

Christine Katlama

series ordinal

4

object named as

C. Katlama

0 references

author name string

P. Cahn

series ordinal

1

0 references

J. Villacian

series ordinal

2

0 references

A. Lazzarin

series ordinal

3

0 references

B. Grinsztejn

series ordinal

5

0 references

K. Arasteh

series ordinal

6

0 references

P. Lopez

series ordinal

7

0 references

N. Clumeck

series ordinal

8

0 references

J. Gerstoft

series ordinal

9

0 references

N. Stavrianeas

series ordinal

10

0 references

S. Moreno

series ordinal

11

0 references

D. Neubacher

series ordinal

13

0 references

D. Mayers

series ordinal

14

0 references

language of work or name

English

0 references

publication date

15 November 2006

0 references

published in

Clinical Infectious Diseases

0 references

volume

43

0 references

issue

10

0 references

page(s)

1347-1356

0 references

Identifiers

0 references

0 references

(Q58291350)

Ritonavir-Boosted Tipranavir Demonstrates Superior Efficacy to Ritonavir-Boosted Protease Inhibitors in Treatment-Experienced HIV-Infected Patients: 24-Week Results of the RESIST-2 Trial

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)